These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 7475042)
21. Effects of a K+ATP channel opener, lemakalim, on systemic, coronary and regional vascular dynamics in conscious dogs: comparison with nifedipine, adenosine, nitroglycerin and acetylcholine. Shen YT; Vatner SF J Pharmacol Exp Ther; 1993 May; 265(2):1026-37. PubMed ID: 8496801 [TBL] [Abstract][Full Text] [Related]
22. Cardiovascular effects of YM099, a novel K+ channel opener, in anesthetized and conscious dogs. Uchida W; Hirano Y; Taguchi T; Masuda N; Shirai Y; Satoh N; Takenaka T Eur J Pharmacol; 1994 Nov; 264(3):285-93. PubMed ID: 7698167 [TBL] [Abstract][Full Text] [Related]
23. Pharmacological analysis of the effect of KRN2391 on coronary vasculature in perfused rat heart. Miwa A; Jinno Y; Yokoyama T; Izawa T; Ogawa N Gen Pharmacol; 1994 May; 25(3):471-4. PubMed ID: 7926593 [TBL] [Abstract][Full Text] [Related]
24. Levcromakalim-induced modulation of membrane potassium currents, intracellular calcium and mechanical activity in rat mesenteric artery. Criddle DN; Greenwood IA; Weston AH Naunyn Schmiedebergs Arch Pharmacol; 1994 Apr; 349(4):422-30. PubMed ID: 8058114 [TBL] [Abstract][Full Text] [Related]
25. Cardiovascular pharmacology of SKP-450, a new potassium channel activator, and its major metabolites SKP-818 and SKP-310. Shin HS; Seo HW; Yoo SE; Lee BH Pharmacology; 1998 Mar; 56(3):111-24. PubMed ID: 9532610 [TBL] [Abstract][Full Text] [Related]
26. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers. Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579 [TBL] [Abstract][Full Text] [Related]
27. Effects of nilvadipine on the cardiovascular system in experimental animals. Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444 [TBL] [Abstract][Full Text] [Related]
28. Hemodynamic and cardiac effects of BMS-180448, a novel K+ATP opener, in anesthetized dogs and isolated rat hearts. D'Alonzo AJ; Grover GJ; Darbenzio RB; Sewter JC; Hess TA; Dzwonczyk S; Sleph PG Pharmacology; 1996 Feb; 52(2):101-12. PubMed ID: 8851631 [TBL] [Abstract][Full Text] [Related]
29. Antihypertensive and cardiovascular effects of a new potassium channel opener, TCV-295, in rats and dogs. Kusumoto K; Awane Y; Kitayoshi T; Fujiwara S; Hashiguchi S; Terashita Z; Shiraishi M; Watanabe T J Cardiovasc Pharmacol; 1994 Dec; 24(6):929-36. PubMed ID: 7898076 [TBL] [Abstract][Full Text] [Related]
30. Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle. Perez-Vizcaino F; Casis O; Rodriguez R; Gomez LA; Garcia Rafanell J; Tamargo J Br J Pharmacol; 1993 Nov; 110(3):1165-71. PubMed ID: 8298804 [TBL] [Abstract][Full Text] [Related]
31. Comparison of KRN2391 with nicorandil and nifedipine on canine coronary blood flow: antagonism by glibenclamide. Ogawa N; Fukata Y; Kaneta S; Jinno Y; Fukushima H; Nishikori K J Cardiovasc Pharmacol; 1992 Jul; 20(1):11-7. PubMed ID: 1383619 [TBL] [Abstract][Full Text] [Related]
32. The antihypertensive and cardioprotective effects of (-)-MJ-451, an ATP-sensitive K(+) channel opener. Lee YM; Yen MH; Peng YY; Sheu JR; Chen YC; Chang MJ; Cheng CY Eur J Pharmacol; 2000 May; 397(1):151-60. PubMed ID: 10844109 [TBL] [Abstract][Full Text] [Related]
33. ATP-sensitive potassium channels in isolated rat aorta during physiologic, hypoxic, and low-glucose conditions. Hüsken BC; Pfaffendorf M; van Zwieten PA J Cardiovasc Pharmacol; 1997 Jan; 29(1):130-5. PubMed ID: 9007682 [TBL] [Abstract][Full Text] [Related]
34. Anti- and proconvulsive actions of levcromakalim, an opener of ATP-sensitive K+ channel, in the model of hippocampus-generating partial seizures in rats. Katsumori H; Ito Y; Higashida H; Hashii M; Minabe Y Eur J Pharmacol; 1996 Sep; 311(1):37-44. PubMed ID: 8884234 [TBL] [Abstract][Full Text] [Related]
35. Characteristics of KRN2391, a novel vasodilator, compared with those of cromakalim, pinacidil and nifedipine in rat aorta. Kashiwabara T; Nakajima S; Izawa T; Fukushima H; Nishikori K Eur J Pharmacol; 1991 Apr; 196(1):1-7. PubMed ID: 1678711 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological analysis of the inhibitory effects of KRN2391 on endothelin-1-induced contraction in isolated large coronary artery of the pig. Harada K; Miwa A; Yokoyama T; Izawa T; Ogawa N; Jinno Y Gen Pharmacol; 1994 Sep; 25(5):935-9. PubMed ID: 7835640 [TBL] [Abstract][Full Text] [Related]